{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:25:59Z","timestamp":1757705159082},"reference-count":27,"publisher":"Informa UK Limited","issue":"sup116","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Rheumatology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1080\/03009740232081788832","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T07:16:36Z","timestamp":1287558996000},"page":"23-27","source":"Crossref","is-referenced-by-count":24,"title":["Collaborative research into outcome measures in Sj\u00f6gren's syndrome"],"prefix":"10.1080","volume":"31","author":[{"given":"S. J.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","volume":"92","author":"Moutsopoulos HM","year":"1980","journal-title":"Annals Intern Med"},{"key":"CIT0002","first-page":"341","volume":"29","author":"Jonsson R","year":"2000","journal-title":"Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheum"},{"issue":"115","key":"CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/030097401300232583","volume":"30","author":"Vivino FB","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"CIT0004","first-page":"70","volume":"1084","author":"Anonymous","year":"2000","journal-title":"The Medical Letter on Drugs and Therapeutics"},{"key":"CIT0006","first-page":"943","volume":"19","author":"Ship JA","year":"1999","journal-title":"Richards AB. Treatment of primary Sjogren's syndrome with low-dose natural interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. J Interferon Cytokine Res"},{"key":"CIT0007","first-page":"255","volume":"18","author":"Shiozawa S","year":"1998","journal-title":"Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerosto-mia in patients with Sjogren's syndrome. J Interferon Cytokine Res"},{"key":"CIT0008","first-page":"550","volume":"24","author":"Vitali C","year":"1997","journal-title":"Proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROC) curve of the criteria performance. J Rheumatol"},{"key":"CIT0009","first-page":"484","volume":"26","author":"Wolfe F","year":"1999","journal-title":"Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol"},{"key":"CIT0010","first-page":"504","volume":"26","author":"Smolen JS","year":"1999","journal-title":"J Rheumatol"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/anr.1780320909","volume":"32","author":"Liang MH","year":"1989","journal-title":"Arthritis Rheum"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303"},{"key":"CIT0014","first-page":"360","volume":"52","author":"Kruize AA","year":"1993","journal-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial. Ann Rheum Dis"},{"issue":"1","key":"CIT0015","first-page":"S31\u2013S36","volume":"5","author":"Fox RI","year":"1996","journal-title":"Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","volume":"58","author":"Tishler M","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"CIT0018","first-page":"1905","volume":"27","author":"Gannot G","year":"2000","journal-title":"Fox PC. Clinical course of primary Sjogren's syndrome: salivary, oral and serologic aspects. J Rheumatol"},{"key":"CIT0019","first-page":"245","volume":"38","author":"Davidson BKS","year":"1999","journal-title":"Griffiths ID. Primary Sjogren's syndrome in the North East of England: a long-term follow-up study. Rheumatology"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03009749709065681","volume":"26","author":"Asmussen K","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"CIT0021","first-page":"693","volume":"13","author":"Oxholm P","year":"1995","journal-title":"Sjogren's syndrome: termino-logy. Clin Exp Rheumatol"},{"issue":"50","key":"CIT0022","first-page":"8","volume":"24","author":"Manthorpe R","year":"1997","journal-title":"Primary Sjogren's syndrome: diagnostic criteria, clinical features, and disease activity. J Rheumatol"},{"key":"CIT0023","first-page":"63","volume":"25","author":"Sutcliffe N","year":"1998","journal-title":"J Rheumatol"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"1085 \u20148","DOI":"10.1093\/rheumatology\/40.10.1085","volume":"40","author":"Asmussen KH","year":"2001","journal-title":"Rheumatology"},{"key":"CIT0026","first-page":"615 \u201421","volume":"118","author":"Schiffman RM","year":"2000","journal-title":"Reliability and validity of the ocular surface disease index. Arch Ophthalmol"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.57.1.20","volume":"57","author":"Hay EM","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","volume":"37","author":"Chalder T","year":"1993","journal-title":"J Psychosomatic Res"},{"key":"CIT0030","first-page":"315 \u201425","volume":"39","author":"Smets EM","year":"1995","journal-title":"The Multidimensional Fatigue Inventory [MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res"},{"key":"CIT0032","first-page":"753 \u201462","volume":"37","author":"Schwartz JE","year":"1993","journal-title":"Krupp L.B. The measurement of fatigue: a new instrument. J Psychosomatic Res"},{"key":"CIT0033","first-page":"29 \u201438","volume":"11","author":"Wahren M","year":"1998","journal-title":"Ro\/SS-A and La\/SS-B antibody level variation in patients with Sjogren's syndrome and sys-temic lupus erythematosus. J Autoimmun"}],"container-title":["Scandinavian Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03009740232081788832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T11:17:16Z","timestamp":1497871036000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03009740232081788832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":27,"journal-issue":{"issue":"sup116","published-online":{"date-parts":[[2010,10,20]]},"published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1080\/03009740232081788832"],"URL":"https:\/\/doi.org\/10.1080\/03009740232081788832","relation":{},"ISSN":["0300-9742","1502-7732"],"issn-type":[{"value":"0300-9742","type":"print"},{"value":"1502-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}